Last update 09 Nov 2024

DS-96432529

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
3-amino-4-{(3S)-3-[(2-ethoxyethoxy)methyl]piperidin-1-yl}thieno[2,3-b]pyridine-2-carboxamide, DS 96432529, DS96432529
Target
CDK8
Mechanism
CDK8 inhibitors(Cyclin-dependent kinase 8 inhibitors)
Therapeutic Areas
Endocrinology and Metabolic DiseaseSkin and Musculoskeletal Diseases
Active Indication
Osteoporosis
Inactive Indication-
Originator Organization
Daiichi Sankyo Co., Ltd.Daiichi Sankyo Co., Ltd.
Active Organization
Daiichi Sankyo Co., Ltd.Daiichi Sankyo Co., Ltd.
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure

Molecular FormulaC18H26N4O3S
InChIKeyGOAKYBVMJUXOFY-LBPRGKRZSA-N
CAS Registry2871872-79-4

Related

100 Clinical Results associated with DS-96432529
Login to view more data
100 Translational Medicine associated with DS-96432529
Login to view more data
100 Patents (Medical) associated with DS-96432529
Login to view more data
1
Literatures (Medical) associated with DS-96432529
01 Dec 2021Bioorganic & medicinal chemistry lettersQ4 · MEDICINE
Discovery of 3-amino-4-{(3S)-3-[(2-ethoxyethoxy)methyl]piperidin-1-yl}thieno[2,3-b]pyridine-2-carboxamide (DS96432529): A potent and orally active bone anabolic agent
Q4 · MEDICINE
100 Deals associated with DS-96432529
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
OsteoporosisPreclinical
JP
Daiichi Sankyo Co., Ltd.Daiichi Sankyo Co., Ltd.
01 Dec 2021
Bone Diseases, MetabolicPreclinical
JP
Daiichi Sankyo Co., Ltd.Daiichi Sankyo Co., Ltd.
09 Sep 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free